France· FR:62529551
KYPROLIS 10 mg, poudre pour solution pour perfusion
A medicinal product containing carfilzomib, registered in France by AMGEN EUROPE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CARFILZOMIB
- Manufacturer
- AMGEN EUROPE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550264261 flacon en verre de 10 mg (2 mg/mL)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carfilzomib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandKyprolisAmgen Europe B.V.
- SpainKYPROLIS 10 MG POLVO PARA SOLUCION PARA PERFUSIONAmgen Europe B.V.
- NorwayKyprolisAbacus Medicine A/S
- United KingdomKyprolis 10mg powder for solution for infusion vialsAmgen Ltd
- United StatesKYPROLISOnyx Pharmaceuticals, Inc.
- CanadaKYPROLISAMGEN CANADA INC
- SwitzerlandKyprolis
- CzechiaKYPROLISAmgen Europe B.V., Breda
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Kyprolis
- Norway · Kyprolis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d42e84bd-3cda-41ba-a95a-8be7c83d6424 GET /v1/drugs/d42e84bd-3cda-41ba-a95a-8be7c83d6424?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62529551",
"date_amm": "2016-12-12",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1060",
"substance": "CARFILZOMIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about carfilzomib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.